Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal secretory calcium-dependent pathway is a physiological mechanism responsible for the secretion of chloride ions and water into the intestinal lumen in response to elevated intracellular calcium levels (Source: NIH, 2019). This pathway is primarily mediated by calcium-activated chloride channels (CaCCs), with Anoctamin-1 (TMEM16A) being the most prominent molecular component identified in the intestinal epithelium (Source: Exp Mol Med, 2019). Activation of these channels creates an electrochemical gradient that drives chloride exit, followed by sodium and water, which helps lubricate the gut and maintain mucosal homeostasis. However, overactivation of this pathway by enterotoxins or inflammatory mediators leads to secretory diarrhea, characterized by excessive fluid loss (Source: JCI Insight, 2019). Drugs like crofelemer target this pathway by inhibiting CaCCs, thereby reducing the volume of fluid secreted into the gut (Source: FDA, 2012). This mechanism is particularly relevant in the management of non-infectious diarrhea in patients with HIV/AIDS on antiretroviral therapy. Understanding this pathway is crucial for developing antisecretory therapies that can treat various forms of watery diarrhea without significantly affecting intestinal motility.
Inhibition of apical calcium-activated chloride channels to reduce the efflux of chloride ions and subsequent water loss into the intestinal lumen.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium-activated chloride channel (CaCC) (CaCC).